News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
688,214 Results
Type
Article (50498)
Company Profile (346)
Press Release (637370)
Section
Business (197361)
Career Advice (2853)
Deals (34735)
Drug Delivery (102)
Drug Development (80585)
Employer Resources (166)
FDA (16421)
Job Trends (15485)
News (336211)
Policy (31481)
Tag
Academia (2874)
Alliances (50180)
Alzheimer's disease (1402)
Approvals (16391)
Artificial intelligence (220)
Bankruptcy (325)
Best Places to Work (12354)
Biotechnology (244)
Breast cancer (236)
Cancer (1782)
Cardiovascular disease (143)
Career advice (2372)
CAR-T (135)
Cell therapy (388)
Clinical research (64543)
Collaboration (719)
Compensation (379)
COVID-19 (2751)
C-suite (170)
Data (1667)
Diabetes (217)
Diagnostics (6703)
Earnings (76024)
Employer resources (147)
Events (110305)
Executive appointments (601)
FDA (17355)
Funding (635)
Gene therapy (272)
GLP-1 (696)
Government (4491)
Healthcare (20236)
Infectious disease (2865)
Inflammatory bowel disease (132)
Interviews (548)
IPO (16834)
Job creations (3613)
Job search strategy (1981)
Layoffs (482)
Legal (6945)
Lung cancer (259)
Manufacturing (251)
Medical device (14241)
Medtech (14246)
Mergers & acquisitions (18329)
Metabolic disorders (571)
Neuroscience (1846)
NextGen: Class of 2025 (7213)
Non-profit (4938)
Northern California (2142)
Obesity (313)
Opinion (242)
Patents (170)
People (57861)
Phase I (20376)
Phase II (28692)
Phase III (21183)
Pipeline (734)
Postmarket research (2214)
Preclinical (8591)
Radiopharmaceuticals (262)
Rare diseases (349)
Real estate (5945)
Regulatory (21847)
Research institute (2580)
Resumes & cover letters (454)
Southern California (1843)
Startups (3790)
United States (19269)
Vaccines (682)
Weight loss (221)
Date
Today (11)
Last 7 days (622)
Last 30 days (2651)
Last 365 days (36194)
2025 (4703)
2024 (37074)
2023 (42137)
2022 (53544)
2021 (58288)
2020 (56933)
2019 (50133)
2018 (38014)
2017 (34407)
2016 (33571)
2015 (39078)
2014 (30232)
2013 (24921)
2012 (26478)
2011 (27017)
2010 (23965)
Location
Africa (885)
Arizona (163)
Asia (41142)
Australia (7208)
California (4925)
Canada (1742)
China (409)
Colorado (225)
Connecticut (247)
Europe (93765)
Florida (709)
Georgia (177)
Illinois (494)
Indiana (272)
Maryland (769)
Massachusetts (3817)
Michigan (218)
Minnesota (354)
New Jersey (1389)
New York (1399)
North Carolina (937)
Northern California (2142)
Ohio (182)
Pennsylvania (1121)
South America (1207)
Southern California (1843)
Texas (720)
Utah (152)
Washington State (491)
688,214 Results for "karolinska development ab".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Renal Research Institute and Karolinska Institutet announce chronic kidney disease management symposium, highlighting new therapeutics
Renal Research Institute, a global leader in dialysis and nephrology research and a subsidiary of Fresenius Medical Care AG, announced together with the Karolinska Institutet a joint symposium, “Prevention of CKD progression: the impact of new therapeutics.” The Karolinska Institutet is one of the world’s leading medical universities.
May 17, 2024
·
3 min read
AB Science provides a summary of the live webcast held on March 4, 2024 giving an update on AB Science development
AB Science SA is providing a summary of the live webcast held on March 4, 2024, giving an update on AB Science development.
March 7, 2024
·
11 min read
Press Releases
Candid Therapeutics and Ab Studio Enter Into Research Collaboration to Discover and Develop Novel T Cell Engagers for Autoimmune Indications
December 16, 2024
·
2 min read
Press Releases
AB Science will participate in the Biomed Forum investors conference
January 22, 2025
·
2 min read
Press Releases
AB Science today provides an update on its masitinib platform
January 30, 2025
·
4 min read
Press Releases
Relmada Therapeutics Acquires Potential Therapy for Tourette Syndrome from Asarina Pharma AB
February 6, 2025
·
7 min read
Press Releases
Pharming Technologies B.V. increases its ownership in Abliva AB (publ) to 92.70 percent
February 21, 2025
·
11 min read
Business
Anocca AB and Shinobi Therapeutics Announce Strategic Partnership to Develop Allogeneic TCR-T Cell Therapies in Oncology
Anocca AB and Shinobi Therapeutics announced a strategic partnership to use Shinobi’s proprietary immune evasive iPS-T cell platform with novel candidate TCRs, discovered and validated by Anocca, to develop a new class of off-the-shelf allogeneic TCR engineered iPS-T-cell therapies for solid tumors.
May 30, 2024
·
4 min read
XNK Therapeutics enters into research collaboration with Karolinska University Hospital in acute myeloid leukemia (AML)
XNK Therapeutics AB announced that the company has entered into a research collaboration with the Karolinska University Hospital, Sweden, to evaluate the suitability of the company’s autologous natural killer cell therapy candidate XNK02 as a novel therapy for treatment of acute myeloid leukemia.
August 24, 2023
·
3 min read
Press Releases
Breckenridge announces final FDA approval for Everolimus tablets for oral suspension, AB-rated to AFINITOR DISPERZ®
January 30, 2025
·
3 min read
1 of 68,822
Next
